Our Company

The world’s largest producer and innovator of natural astaxanthin.

AstaReal Inc. is part of AstaReal Holdings Co., Ltd. which is a wholly owned subsidiary of Fuji Chemical Group. AstaReal Inc. is a sales and marketing company servicing North and South America. Our natural astaxanthin is cultivated, grown and harvested in our manufacturing facility in Moses Lake, Washington. As the global demand for natural astaxanthin continues to grow, we will continue to be fully dedicated to ensuring the supply of premium, natural astaxanthin products.

U.S.A – AstaReal, Inc.

Sales & Marketing Office
3 Terri Lane, Unit 12
Burlington, NJ 08016

Production
7761 Randolph Rd. NE
Moses Lake, WA 98837

www.astarealusa.com
contact@astarealusa.com

Sweden- AstaReal AB

Idrottsvägen 4, 134 40
Gustavsberg, Sweden

www.astareal.se
info@astareal.se

Corporate Headquarters- AstaReal Co., Ltd.

The Front Tower Shiba Koen,
12th Floor, 2-6-3 Shiba Koen
Minato-ku, Tokyo 105-0011
www.astareal.com

Our Product – AstaReal®

AstaReal Natural Astaxanthin—supported by technology and science

Safety

  • Non-GMO Project Verified
  • Resistant to contamination  and chlorophyll
  • cGMP
  • HACCP
  • Successful FDA GRAS and NDI  notifications

Quality

  • Prestine level of quality  control and quality  assurance
  • Consistent high quality and  stability
  • Eco friendly

Supply

Our original facility is located in Gustavsberg, Sweden. In order to keep up with growing demand in North and South American region, we have opened a new, state of the art facility, located in Moses Lake, Washington. With two production facilities, AstaReal is able to offer stable supply through our indoor production technology.

Source of AstaReal® – Haematococcus Pluvialis – Fresh Water Microalgae

Haematococcus pluvialis is a freshwater microalga belonging to family Chlamydomonadaceae. Strains of the alga extend across habitats ranging from the African lakes to the Arctic snow fields. Typical habitats are ephemeral ponds and rainwater pools, for example, rock pools in the Stockholm archipelago.

Under favorable conditions, the motile, green cells of Haematococcus pluvialis thrive, reproducing primarily by other unfavorable conditions, the cells enter a resting state and become spores with thick cell walls. When transforming into this spore phase, these algae not only store fats as an energy source, but also begin producing and accumulating astaxanthin.

 

Astaxanthin acts like a force field that protects the nuclear DNA and cell contentfrom oxidation and UVA radiation. The encapsulated form of the algae is calledan aplanospore and in this form, the algae can survive for long periods, evenunder harsh conditions.

Source Average Astaxanthin Content
Lobster, Crawfish 0.3mg / 100g
Salmon 3mg / 100g
Krill 4mg / 100g
Phaffia Yeast 800mg / 100g
Haematococcus Pluvialis Microalgae (Source of AstaREAL Astaxanthin) 6,000mg / 100g

Production – Unique and Ultra-Clean Cultivation Using Photobioreactors

AstaReal was the first company in the world to commercially produce natural astaxanthin from Haematococcus pluvialis. AstaReal has a production facility in Gustavsberg, Sweden and in Moses Lake, Washington in the United States. Thanks to our high level of expertise and long-term experience in the production of microalgae, we can offer the best quality product with the highest amount of astaxanthin per kilogram of biomass.

The algae is grown in stainless steel photo bioreactors under carefully controlled indoor sterile conditions to enable a more effective, cleaner, and safer process. Our equipment is of the highest quality, and the production is both ISO 9001 and HACCP certified.

Cultivation starts with the “seed” which is enriched with essential nutrients that provide the algae with optimal conditions for rapid growth and proliferation (Green Phase). When the culture has reached its optimum density in the Green Phase, the production of astaxanthin is induced (Red Phase). After harvest, the algae are crushed and finally dried.

The final biomass is a deep-red powder containing a high concentration of astaxanthin. This can then be further refined to create a high purity, raw material ingredient that is used in the manufacture of various products, such as dietary supplements, foods, and cosmetics.

safety

Safety – The Most Studied Brand of Natural Astaxanthin

There are over 400 peer reviewed studies on astaxanthin. AstaReal® has been featured in the vast majority of these studies. The clinical database for AstaReal® contains over 50 human studies, including 23 double-blind, placebo-controlled trials, with more than 1,400 participants undergoing treatments lasting from 2 weeks to 6 months. The doses used in these trials ranged from 2 to 45 mg/day. The trials were designed to determine the efficacy, safety, and tolerance of AstaReal® astaxanthin for different doses, treatment periods, study designs, and demographic variables including age, gender, and ethnicity. All studies revealed no adverse effects based on hematological findings, serum chemistry, urinal analysis, and self-report questionnaires.

Discover More About Safety Studies

Patents – Leader in Astaxanthin Patents for Human and Animal Health

Patent Title for Human Health Patent Number
Agents for relieving eye controlling function error EP 1396264
Oral preparation for the prophylactic and therapeutic treatment of Helicobacter sp.infection US 6262316
Medicament for improvement of duration of muscle function or treatment of muscledisorders or diseases US 6245818
Use of xanthophylls for improvement of duration of muscle function or treatment of muscle disorders CA 2299366
Method of increasing the production and improving the quality of semen US 6410602
Method of the prophylactic treatment of mastitis US 6335015
Treatment of dyspepsia US 6923967
Use of xanthophylls astaxanthin e.g. for treatment of autoimmune diseases chronic viral and intracellular bacterial infections US 6773708
Method of inhibiting the expression of inflammatory cytokines and chemokines US 078040
Composition for body fat reduction JP 5165894
Patent Title for Animals Patent Number
Method for increasing the production of/in breeding and production animals in the poultry industry US 5744502
Agent for increasing the production of/in breeding and production mammals US 6054491
Patent Title for Device and Chemical Products Patent Number
Fine algae culture device US 6348347
Method of preventing discoloration of carotenoid pigment and container used therefor EP 2322579